228 related articles for article (PubMed ID: 20947516)
1. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.
Nguyen GH; Schetter AJ; Chou DB; Bowman ED; Zhao R; Hawkes JE; Mathé EA; Kumamoto K; Zhao Y; Budhu A; Hagiwara N; Wang XW; Miyashita M; Casson AG; Harris CC
Clin Cancer Res; 2010 Dec; 16(23):5824-34. PubMed ID: 20947516
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
[TBL] [Abstract][Full Text] [Related]
4. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
[TBL] [Abstract][Full Text] [Related]
5. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
[TBL] [Abstract][Full Text] [Related]
6. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
10. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.
Schetter AJ; Nguyen GH; Bowman ED; Mathé EA; Yuen ST; Hawkes JE; Croce CM; Leung SY; Harris CC
Clin Cancer Res; 2009 Sep; 15(18):5878-87. PubMed ID: 19737943
[TBL] [Abstract][Full Text] [Related]
11. microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma.
Zhao Y; Schetter AJ; Yang GB; Nguyen G; Mathé EA; Li P; Cai H; Yu L; Liu F; Hang D; Yang H; Wang XW; Ke Y; Harris CC
Int J Cancer; 2013 Jun; 132(12):2901-9. PubMed ID: 23175214
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
Streppel MM; Pai S; Campbell NR; Hu C; Yabuuchi S; Canto MI; Wang JS; Montgomery EA; Maitra A
Clin Cancer Res; 2013 Aug; 19(15):4067-78. PubMed ID: 23757351
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival.
Mathé EA; Nguyen GH; Bowman ED; Zhao Y; Budhu A; Schetter AJ; Braun R; Reimers M; Kumamoto K; Hughes D; Altorki NK; Casson AG; Liu CG; Wang XW; Yanaihara N; Hagiwara N; Dannenberg AJ; Miyashita M; Croce CM; Harris CC
Clin Cancer Res; 2009 Oct; 15(19):6192-200. PubMed ID: 19789312
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.
Buas MF; Onstad L; Levine DM; Risch HA; Chow WH; Liu G; Fitzgerald RC; Bernstein L; Ye W; Bird NC; Romero Y; Casson AG; Corley DA; Shaheen NJ; Wu AH; Gammon MD; Reid BJ; Hardie LJ; Peters U; Whiteman DC; Vaughan TL
PLoS One; 2015; 10(6):e0128617. PubMed ID: 26039359
[TBL] [Abstract][Full Text] [Related]
17. miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.
Smith CM; Watson DI; Leong MP; Mayne GC; Michael MZ; Wijnhoven BP; Hussey DJ
World J Gastroenterol; 2011 Feb; 17(8):1036-44. PubMed ID: 21448356
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.
Bansal A; Gupta V; Wang K
J Cell Biochem; 2016 Jun; 117(6):1288-95. PubMed ID: 26808728
[TBL] [Abstract][Full Text] [Related]
19. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
[TBL] [Abstract][Full Text] [Related]
20. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
